首页PRGO • NYSE
add
Perrigo Company PLC
昨日收盘价
$27.08
当日价格范围
$26.96 - $28.12
年度波幅
$23.89 - $34.60
市值
38.30亿 USD
平均交易量
170.94万
市盈率
-
股息率
3.93%
主要交易所
NYSE
相关资讯
财务信息
损益表
收入
净收入
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 10.88亿 | -3.23% |
经营支出 | 2.91亿 | -12.72% |
净收入 | -2100.00万 | -247.89% |
净利润率 | -1.93 | -253.17% |
每股收益 | 0.81 | 26.56% |
息税折旧摊销前利润 | 1.96亿 | 15.93% |
有效税率 | 180.73% | — |
资产负债表
总资产
负债总额
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 14.62亿 | 144.39% |
总资产 | 112.03亿 | 4.14% |
负债总额 | 66.37亿 | 10.25% |
权益总额 | 45.66亿 | — |
发行在外的股份 | 1.36亿 | — |
市净率 | 0.81 | — |
资产回报率 | 2.63% | — |
资本回报率 | 3.09% | — |
现金流
现金净变动
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | -2100.00万 | -247.89% |
来自运营的现金 | 4220.00万 | -66.10% |
投资现金 | 2.13亿 | 792.83% |
融资现金 | 6.53亿 | 1,608.78% |
现金净变动 | 9.21亿 | 2,036.19% |
自由现金流 | 2.20亿 | 174.19% |
简介
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
CEO
成立时间
1887
员工数量
9,140